X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (23) 23
overactive bladder (16) 16
male (15) 15
middle aged (15) 15
urology & nephrology (15) 15
aged (14) 14
mirabegron (14) 14
quality of life (14) 14
urinary incontinence (14) 14
efficacy (12) 12
urinary bladder, overactive - drug therapy (12) 12
analysis (10) 10
solifenacin (10) 10
acetanilides - therapeutic use (9) 9
adherence (9) 9
bladder (9) 9
care and treatment (9) 9
female (9) 9
persistence (9) 9
thiazoles - therapeutic use (9) 9
benign prostatic hyperplasia (8) 8
muscarinic antagonists - therapeutic use (8) 8
therapy (8) 8
united kingdom (8) 8
antimuscarinics (7) 7
cost-benefit analysis (7) 7
double-blind method (7) 7
quality-of-life (7) 7
urological agents - therapeutic use (7) 7
adult (6) 6
health care sciences & services (6) 6
lower urinary tract symptoms (6) 6
management (6) 6
medicine & public health (6) 6
medicine, general & internal (6) 6
patient compliance (6) 6
prostatic hyperplasia - complications (6) 6
retrospective studies (6) 6
safety (6) 6
treatment outcome (6) 6
urogenital system (6) 6
acetanilides - administration & dosage (5) 5
aged, 80 and over (5) 5
beta-adrenoceptor agonist (5) 5
comparative analysis (5) 5
drug therapy, combination (5) 5
incontinence (5) 5
literature reviews (5) 5
lower urinary tract symptoms - drug therapy (5) 5
lower urinary tract symptoms - etiology (5) 5
markov chains (5) 5
muscarinic antagonists - administration & dosage (5) 5
patients (5) 5
prostate (5) 5
research (5) 5
thiazoles - administration & dosage (5) 5
tolterodine (5) 5
urinary bladder, overactive - physiopathology (5) 5
urology (5) 5
acetanilides - economics (4) 4
adrenergic beta-3 receptor agonists - therapeutic use (4) 4
clinical trials (4) 4
cohort studies (4) 4
drug therapy (4) 4
health policy & services (4) 4
hypertrophy (4) 4
impact (4) 4
internal medicine (4) 4
medical research (4) 4
medication adherence - statistics & numerical data (4) 4
muscarinic antagonists (4) 4
muscarinic antagonists - adverse effects (4) 4
muscarinic antagonists - economics (4) 4
oxybutynin (4) 4
severity of illness index (4) 4
solifenacin succinate (4) 4
solifenacin succinate - administration & dosage (4) 4
studies (4) 4
tamsulosin (4) 4
thiazoles - economics (4) 4
tolerability (4) 4
urinary bladder (4) 4
urinary-incontinence (4) 4
urological agents - administration & dosage (4) 4
validation (4) 4
acetanilides - adverse effects (3) 3
adrenergic receptors (3) 3
care (3) 3
constipation (3) 3
cost-effectiveness (3) 3
databases (3) 3
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (3) 3
epiluts (3) 3
health economics (3) 3
health status (3) 3
health-related quality of life (3) 3
journal article (3) 3
medication (3) 3
medication adherence (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurourology and Urodynamics, ISSN 0733-2467, 11/2018, Volume 37, Issue 8, pp. 2945 - 2950
Aims The process of identifying research questions, synthesizing and interpreting evidence, and weight given to health economics differs between the clinical... 
clinical guidelines | neurogenic lower urinary tract dysfunction | CLINICAL-PRACTICE GUIDELINES | MANAGEMENT | UROLOGY & NEPHROLOGY | BLADDER | CARE | Urinary incontinence | Urogenital system | Quality | Urinary tract
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 10/2017, Volume 71, Issue 10, pp. e12996 - n/a
Summary Introduction and objectives Persistence with antimuscarinic (AM) drugs prescribed for overactive bladder (OAB) is poor. This study aimed to compare... 
MEDICINE, GENERAL & INTERNAL | THERAPY | MANAGEMENT | OLDER PATIENTS | EFFICACY | SAFETY | TOLERABILITY | TERMINOLOGY | EXPERIENCE | AGONIST | Urinary incontinence | Family medicine | Oxybutynin | Databases | Analysis | Drugs | Urinary bladder | Acetylcholine receptors | Bladder | Adrenergic receptors | Adhesion | Patients
Journal Article
International Journal of Urology, ISSN 0919-8172, 09/2019, Volume 26, Issue 9, pp. 890 - 896
Objectives To describe quality of life outcomes in patients with overactive bladder aged ≥65 years receiving mirabegron, a β3‐adrenoreceptor agonist (BELIEVE).... 
aged | medication adherence | mirabegron | quality of life | overactive | urinary bladder | CONDITION PPBC | RESPONSIVENESS | OAB-Q | EFFICACY | PERSISTENCE | VALIDATION | SYMPTOMS | ADHERENCE | PERCEPTION | UROLOGY & NEPHROLOGY | QUESTIONNAIRE | Urinary incontinence | Medical research | Care and treatment | Analysis | Medicine, Experimental | Mirabegron | Patient compliance | Bladder | Adrenergic receptors | Clinical medicine | Questionnaires | Quality of life
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 3, pp. 389 - 399
Abstract Background Persistence with antimuscarinic therapy in overactive bladder (OAB) is poor, but may be different for mirabegron, a β3 -adrenoceptor... 
Urology | Adherence | Persistence | Antimuscarinics | Overactive bladder | Observational | Mirabegron | BETA-ADRENOCEPTOR AGONIST | MEDICATION | EFFICACY | SAFETY | TERMINOLOGY | SYMPTOMS | WOMEN | TOLERABILITY | UROLOGY & NEPHROLOGY | EXPERIENCE | URINARY-INCONTINENCE | Acetanilides - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Thiazoles - administration & dosage | Adrenergic beta-3 Receptor Agonists - adverse effects | Thiazoles - adverse effects | Young Adult | Urinary Bladder, Overactive - drug therapy | Urological Agents - adverse effects | Time Factors | Urinary Bladder, Overactive - physiopathology | Aged, 80 and over | Urological Agents - administration & dosage | Adult | Female | Retrospective Studies | Acetanilides - adverse effects | Odds Ratio | Adrenergic beta-3 Receptor Agonists - administration & dosage | Databases, Factual | Urinary Bladder, Overactive - diagnosis | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | United Kingdom | Chi-Square Distribution | Muscarinic Antagonists - administration & dosage | Medication Adherence | Aged | Longitudinal Studies | Urinary incontinence | Medicine, Experimental | Complications and side effects | Medical research | Care and treatment | Patient compliance
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 09/2018, Volume 74, Issue 3, pp. 324 - 333
Mirabegron is an established treatment alternative to antimuscarinic therapy for patients with overactive bladder (OAB), as shown by efficacy and tolerability... 
Network meta-analysis | Antimuscarinics | Overactive bladder | Efficacy | Tolerability | Combination therapy | Mirabegron | Systematic literature review | BETA-ADRENOCEPTOR AGONIST | MEDICATION | SAFETY | PERSISTENCE | PHASE-3 | ADHERENCE | TRIAL | UROLOGY & NEPHROLOGY | AGENTS
Journal Article
NEUROUROLOGY AND URODYNAMICS, ISSN 0733-2467, 03/2018, Volume 37, Issue 3, pp. 986 - 996
AimsTo compare efficacy and tolerability of solifenacin 5mg/day versus other oral antimuscarinic agents for the treatment of overactive bladder (OAB).... 
constipation | solifenacin | PLACEBO | MIRABEGRON | SAFETY | PERSISTENCE | antimuscarinics | micturition | ADHERENCE | dry mouth | THERAPY | incontinence | UROLOGY & NEPHROLOGY | blurred vision | Urinary incontinence | Comparative analysis | Literature reviews | Statistical analysis | Urination | Constipation
Journal Article
Neurourology and Urodynamics, ISSN 0733-2467, 11/2016, Volume 35, Issue 8, p. 987
To assess patient-reported outcomes (PROs) in patients with overactive bladder (OAB) receiving the novel [beta].sub.3-adrenoceptor agonist mirabegron.... 
Clinical trials | Bladder | Patients
Journal Article
Neurourology and Urodynamics, ISSN 0733-2467, 03/2018, Volume 37, Issue 3, pp. 986 - 996
Aims To compare efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents for the treatment of overactive bladder (OAB).... 
constipation | dry mouth | solifenacin | incontinence | antimuscarinics | micturition | blurred vision
Journal Article
Value in Health, ISSN 1098-3015, 2015, Volume 18, Issue 6, pp. 783 - 790
Journal Article